- Home
- ELVN vs TMP Comparison
ELVN vs TMP Comparison
Compare ELVN & TMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ELVN | TMP |
|---|---|---|
| Founded | 2016 | 1836 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 962.3M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ELVN | TMP |
|---|---|---|
| Price | $21.00 | $71.66 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 2 |
| Target Price | $41.20 | ★ $72.00 |
| AVG Volume (30 Days) | ★ 486.5K | 53.0K |
| Earning Date | 11-12-2025 | 10-24-2025 |
| Dividend Yield | N/A | ★ 3.62% |
| EPS Growth | N/A | ★ 27.02 |
| EPS | N/A | ★ 5.90 |
| Revenue | N/A | ★ $316,920,000.00 |
| Revenue This Year | N/A | $16.28 |
| Revenue Next Year | $20.05 | $1.90 |
| P/E Ratio | ★ N/A | $12.17 |
| Revenue Growth | N/A | ★ 10.67 |
| 52 Week Low | $13.30 | $54.16 |
| 52 Week High | $25.96 | $78.50 |
Technical Indicators
Market Signals| Indicator | ELVN | TMP |
|---|---|---|
| Relative Strength Index (RSI) | 51.08 | 66.46 |
| Support Level | $19.58 | $69.00 |
| Resistance Level | $22.14 | $71.81 |
| Average True Range (ATR) | 1.28 | 2.10 |
| MACD | -0.06 | 0.48 |
| Stochastic Oscillator | 41.37 | 94.92 |
Price Performance
Historical ComparisonAbout ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About TMP Tompkins Financial Corporation
Tompkins Financial Corp is a Financial Holding Company. It has three business segments, consisting of banking, insurance and wealth management. It offers various products and services, including commercial and consumer banking, leasing, trust and investment management, financial planning and wealth management, and insurance. Insurance is comprised of property and casualty insurance services and employee benefit consulting. Wealth management activities include the results of the company's trust, financial planning, and wealth management services. The company generates majority of its revenue from Banking segment.